Pendal Group’s Acadia Healthcare ACHC Stock Holding History

Pendal Group’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,100	Closed	-$349K	–	549
2021 Q1	$349K	Buy	+6,100	New	+$330K	﹤0.01%	445

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Pendal Group's ACHC Position: Q2 2021 in Review

Pendal Group sold out of Acadia Healthcare (ACHC) in Q2 2021, closing a stake of 6,100 shares — an estimated $349K sold.

Pendal Group first reported a position in ACHC in Q1 2021 and held it in 1 quarter. The position peaked at $349K in Q1 2021. 285 funds tracked by Wall St. Rank hold ACHC as of Q2 2021.

Pendal Group reported no remaining Acadia Healthcare position as of Q2 2021 after selling out during the quarter.
Pendal Group sold 6,100 Acadia Healthcare shares in Q2 2021, an estimated $349K.
Pendal Group first reported a position in Acadia Healthcare in Q1 2021 and held it in 1 quarter.
Pendal Group's Acadia Healthcare position peaked at $349K in Q1 2021.
285 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2021.

Based on Pendal Group's 13F filing for Q2 2021, filed 28 Jul 2021.